Associate Professor of Pharmacology and Pharmacotherapy at the Faculty of Pharmacy, Universidade de Lisboa. Holds degrees in Pharmaceutical Sciences (PharmD) from the Faculty of Pharmacy, Universidade de Lisboa; an Integrated Master’s Degree in Medicine (MD) from NOVA Medical School – Faculdade de Ciências Médicas; and both a Master’s and a PhD in Pharmacy, specialising in Pharmacology and Pharmacotherapy. He is the Principal Investigator of the Laboratory of Systems Integration Pharmacology, Clinical & Regulatory Science research group at iMed.ULisboa. His research interests include non-clinical pharmacological assessment in local and systemic inflammation, clinical pharmacology, and medicines regulation, with more than 60 international peer-reviewed publications and more than 100 scientific communications. He served as a member of the Directorate-General of Health’s Technical Committee for COVID-19 Vaccination (CTVC) from 2021 to 2022 and of the Pharmacy and Therapeutics Committee of the Lisbon and Tagus Valley Regional Health Administration (ARSLVT) from 2022 to 2023. He is currently a member of INFARMED’s Medicines Evaluation Committee, a Clinical Pharmacology Expert at the European Medicines Agency (EMA), a member of the EMA’s Committee for Orphan Medicinal Products (COMP), a member of the EMA’s Healthcare Professionals Working Party (HCPWP), and a member of the Therapies Scientific Committee (TSC) of the International Rare Diseases Research Consortium (IRDiRC).